AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

AstraZeneca and Bristol Myers Squibb held preliminary acquisition discussions, according to reports. The talks prompted movement in both companies' share prices. The potential transaction would represent a shift in AstraZeneca's acquisition strategy over the past decade.

Next story